ACCCBUZZ BLOG

For many community sites, the question is not whether to offer BsAbs but how to implement them safely and sustainably. Recognizing these needs, ACCC developed 2 practical, implementation-focused tools to support programs at every stage of readiness.

ACCC is excited to share its new provider resources for TIL cell therapy, including a referral readiness checklist, patient pathway guide, and white paper with tangible steps for improving access.

The JADPRO Live 2025 conference convened thousands of APPs in hematology and oncology for 4 days of clinical education, collaboration, and professional growth.

To help teams navigate treatment decisions for Relapsed/refractory (R/R) follicular lymphoma (FL), ACCC developed an Effective Practice Guide (EPG) that focuses on practical strategies for delivering high-quality care. 

The Vol 40 No 5 issue of the Association of Cancer Care Centers’ (ACCC) peer-reviewed, bimonthly journal, Oncology Issues, has 7 feature articles offering insights and solutions that are valuable to every member of the multidisciplinary cancer care team.

The final day of the 42nd National Oncology Conference featured panels that brought together leaders and innovators to discuss clinical and administrative priorities, coordinating with primary care, and challenges in rural and remote communities.

Day 2 of the 42nd National Oncology Conference (NOC) offered powerful insights about creating a trusting and engaged workforce, making the business case for an innovation, and the presentations of the six 2025 Innovator Award Winners.

Day 1 of the ACCC 42nd National Oncology Conference (NOC) featured discussions of psychosocial care and a fireside chat with ACCC President, Una Hopkins, DNP, MSN, FNP-BC, NE-BC, RN, FACCC.

Breast Cancer Awareness Month, observed each year in October, recognizes the research, advocacy, and strength of patients that have led to treatment advances for the most common cancer diagnosis in women.

In recognition of the importance of mental well-being and mental health services, ACCC highlights 3 thought leadership pieces featured in recent volumes of Oncology Issues that tackle mental health–forward interventions for both patients and providers.

A panel of industry leaders gathered to unpack the potential impacts of the administration’s actions relating to Most Favored Nation (MFN) drug pricing, offering insight into what MFN could mean for pharmaceutical companies, payers, and patients.

The recent NCCN summit provided an opportunity for providers, payers, and patient advocates to discuss policy and strategies on the current application of AI in practice, its promise for care improvement, and strategies to mitigate the risks AI poses.

The NCCN hosted a 1-day summit on September 9 all about AI in cancer care: how it’s being used today, where the field is moving in the future, and challenges that will require innovative and collaborative solutions.

In honor of Hereditary Cancer Awareness Week, observed this year from September 29 to October 5, ACCC is highlighting 2 initiatives from its member programs that expanded genetic testing for hereditary cancers.

A recent ACCC virtual office hours session unpacked the real-world challenges of Bispecific Antibodies—from reimbursement roadblocks to operational logistics—and offered strategies to navigate them more effectively.

September is Gynecologic Cancer Awareness Month, a chance to highlight cancers that originate in the endometrium, ovary, and cervix, and to recognize efforts to improve patient outcomes for cancer types with poor prognoses and limited treatment options.

Supporting AYAs with cancer truly takes a village. Multidisciplinary collaboration, community partnerships, survivorship champions, and patient voices are all essential to building programs that meet the needs of this diverse population.

Leaders at Mary Bird Perkins Cancer Center have rebuilt their now nationally recognized clinical trials program from the ground up, with diverse enrollment a cornerstone of their philosophy.

September is Blood Cancer Awareness month, an opportunity to spotlight the broad category of diseases that include leukemia, lymphoma, plasma cell neoplasms, myelodysplastic syndromes, and myeloproliferative neoplasms.